Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Memorial Sloan-Kettering Cancer Center |
---|---|
Information provided by: | Memorial Sloan-Kettering Cancer Center |
ClinicalTrials.gov Identifier: | NCT00598117 |
The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will provide important information that can be used to develop programs to improve the quality of life of patients with esophageal cancer.
Condition | Intervention |
---|---|
Esophageal Cancer |
Behavioral: Questionnaires |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Quality Of Life Outcomes Following Treatment for Esophageal Cancer |
Estimated Enrollment: | 450 |
Study Start Date: | August 2003 |
Estimated Study Completion Date: | August 2010 |
Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
1
Group 1 (newly diagnosed patients) Initial assessment → first post op visit → 6 and 12 months post surgery
|
Behavioral: Questionnaires
Newly diagnosed patients will be assessed at four points Time 1 (prior to treatment)
|
2
Group 2 (post-treatment patients) A one-time assessment will be conducted at least 18 months following treatment
|
Behavioral: Questionnaires
Newly diagnosed patients will be assessed at four points Time 1 (prior to treatment)
|
In order to determine the impact of esophageal cancer and its treatment on patients' quality of life over time, this study will prospectively follow a cohort of patients at specified intervals, evaluating their physical symptoms, physical and social functioning and overall quality of life. Medical and sociodemographic factors as well as health behaviors that might be predictive of adaptation will be tested. This is a preliminary investigation and it is hoped that we will be able to base future research questions on the results of this study.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
This is a descriptive study comprising two cohorts of esophageal cancer patients. The first cohort will be followed prospectively and will include patients newly diagnosed with esophageal cancer prior to treatment. QOL assessments will be administered pre-surgery, at first post-operative visit, and at 6 and 12 months post surgery. The second cohort will be a cross sectional sample and include patients more than 18 months post treatment, without evidence of disease who will undergo one QOL assessment. This is a preliminary investigation and it is hoped that we will be able to base future research questions on our results of this study.
Inclusion Criteria:
Exclusion Criteria:
Contact: Manjit Bains, MD | bainsm@mskcc.org |
United States, New York | |
Memorial Sloan Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 |
Principal Investigator: | Manjit Bains, MD | Memorial Sloan-Kettering Cancer Center |
Responsible Party: | Memorial Sloan-Kettering Cancer Center ( Bains, Manjit, MD / Principal Investigator ) |
Study ID Numbers: | 03-083 |
Study First Received: | January 9, 2008 |
Last Updated: | July 9, 2009 |
ClinicalTrials.gov Identifier: | NCT00598117 History of Changes |
Health Authority: | United States: Institutional Review Board |
Esophageal CancerEsophagus |
Digestive System Neoplasms Digestive System Diseases Esophageal Disorder Gastrointestinal Diseases Head and Neck Neoplasms |
Esophageal Neoplasms Quality of Life Gastrointestinal Neoplasms Esophageal Cancer Esophageal Diseases |
Neoplasms Neoplasms by Site Digestive System Neoplasms Digestive System Diseases Gastrointestinal Diseases |
Head and Neck Neoplasms Esophageal Neoplasms Gastrointestinal Neoplasms Esophageal Diseases |